Population-based studies were eligible for inclusion. The included studies were prospective and retrospective.
detected per foetus.
The authors did not state how the papers were assessed for quality, or how many reviewers performed the quality assessment.
Data extraction
The authors did not state how the data were extracted for the review, or how many reviewers performed the data extraction. Data were extracted on the detection rate in each trimester (including the sensitivity and specificity), the overall detection rates, the prevalence of anomalous foetuses and anomalies (including false-positives), and termination of the pregnancy.
Methods of synthesis
How were the studies combined?
The results of each included study were tabulated and combined in a narrative discussion.
How were differences between studies investigated?
Differences between the studies were assessed narratively according to the trimester of pregnancy, the study design used, the method of reporting and defining the outcome, and the setting and individual performing the scan.
Results of the review
Eleven studies (96,633 foetuses, including multiple pregnancies)) were included in the review: 1 randomised controlled trial (7,575 foetuses), 4 prospective studies (35,710 foetuses) and 6 retrospective studies (53,348 foetuses).
Number of false-positives.
A total of 52 false-positives were reported in the included studies. None of the false-positives were associated with lethal anomalies; 19 were associated with possible survival and long-term morbidity; 2 were amenable to intrauterine therapy; 18 were associated with possible short-term or immediate morbidity; 10 were associated with either long-term or short-term morbidity; a further 3 could not be classified.
Detection of anomalies.
First trimester (less than 15 weeks): none of the included studies reported the detection of anomalies during the first trimester.
Second trimester (less than 24 weeks): the overall sensitivity of second trimester scanning was 41.3% (range: 13.5 to 85.3). The sensitivity was lower in studies where the gestational age range at scanning was less than 18 weeks (5 studies; overall sensitivity 21.5%, range: 16.6 to 71.4) than in those where the gestational age was greater than 18 weeks (6 studies; overall sensitivity 51%, range: 13.5 to 85.3). The overall specificity was 99.94% (range: 99.4 to 100), based on 10 studies.
The detection rates for anomalies at different anatomical systems were: 76.4% for the central nervous system (CNS), 67.3% for the urinary tract, 50% for pulmonary, 41.9% for gastrointestinal, 23.8% for skeletal and 17.4% for cardiac. The detection rate for chromosomal abnormalities was 18.8%. Third trimester (greater than 24 weeks): the overall sensitivity of third trimester scanning was 18.6% (range: 18.2 to 40.4), based on 4 studies. Specificity was 100% (1 study).
